COVID-19
As the coronavirus (COVID-19) continues to spread, ASCO is committed to providing the most current information and resources to its members and the larger oncology community to help ensure that individuals with cancer receive high-quality care. ASCO has compiled a wide range of resources to support clinicians, the cancer care delivery team, and patients with cancer. This is a rapidly evolving situation and ASCO resources will be updated on a regular basis. Please continue to check back for the most current information. We are united in working together to continue the critical work of conquering cancer during this health care crisis. Visit ASCO COVID-19 resources. Visit ASCO's COVID-19 resources.
CancerLinQ Insights
Updated July 7, 2020 - Demographics of Patients with Cancer and COVID-19 Disease
CancerLinQ Data
UPDATED DATA: CancerLinQ continues to monitor COVID diagnoses among active cancer patients in our database of 1.5 million total cancer patients
Updated June 23, 2020 - Demographics of Patients with Cancer and COVID-19 Disease
CancerLinQ Data
UPDATED DATA: CancerLinQ continues to monitor COVID diagnoses among active cancer patients in our database of 1.5 million total cancer patients
Updated June 15, 2020 - Demographics of Patients with Cancer and COVID-19 Disease
CancerLinQ Data
UPDATED DATA: CancerLinQ continues to monitor COVID diagnoses among active cancer patients in our database of 1.5 million total cancer patients
Updated June 8, 2020 - Demographics of Patients with Cancer and COVID-19 disease
CancerLinQ Data
UPDATED DATA: CancerLinQ continues to monitor COVID diagnoses among active cancer patients in our database of 1.5 million total cancer patients
Impact of COVID-19 Disease on Oncology Practice: Targeted Therapies Used in Lung Cancer
COVID-19 Surveillance Report
Trends in prescription and/or administration of targeted therapies used in lung cancer by month since January 2019
Updated June 2, 2020 - Demographics of Patients with Cancer and COVID-19 Disease
CancerLinQ Data
UPDATED DATA: CancerLinQ continues to monitor COVID diagnoses among active cancer patients in our database of 1.5 million total cancer patients
